INS and metabolic syndrome: The obvious difference between the mean values for the II found in non-diabetic versus diabetic MetS patients appears compatible with the hypothesis that, in patients affected by the MetS, the insulin secretory response of the endocrine pancreas to extracellular glucose is indeed perturbed in parallel with the worsening of glucose homeostasis [37,41,42,43,44].